By Rishika Sadam July 9 (Reuters) - Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in ...

Danish drugmaker Novo Nordisk, launched its weekly basal insulin injection, Awiqli, in India on Thursday, aiming to compete ...

Awiqli offers adults with diabetes fewer injections while maintaining effective blood sugar control through weekly dosing.

Awiqli, the world's first once-a-week basal insulin, has been launched in India, reducing insulin injections from 365 to 52 a ...

Danish drugmaker Novo Nordisk has launched Awiqli, the world’s first once-weekly basal insulin, in India. Here’s how it works ...

Danish pharmaceutical company Novo Nordisk has introduced a once-weekly basal insulin injection, Awiqli, which will allow ...

Novo Nordisk says Awiqli can cut basal insulin shots from 365 to 52 a year, targeting delayed insulin use in India’s vast ...

Danish drugmaker Novo Nordisk launched its weekly basal insulin injection, Awiqli, in India on Thursday, where diabetes rates ...

Novo Nordisk India launched Awiqli, the first once-weekly basal insulin for diabetes, reducing injections from daily to ...

India: Awiqli (insulin icodec), a once-weekly basal insulin injection for adults with type 1 and type 2 diabetes, has been ...

India has become one of the first countries in the world to introduce Awiqli, the world's first once-a-week basal insulin ...